Crista Galli Ventures

Pear Bio is a Boston and London-based AI-enabled biotech company. We develop functional precision medicine-guided therapeutics for patients with hard-to-treat cancers. We take tumor biopsies and blood from cancer patients to find new targets with multi-omics. We then test the efficacy of generated drug candidates directly on patient tumor samples using a proprietary immune-microtumor system. We have best-in-class and first-in-class internal drug discovery programs, and we are using our 3D immune-microtumor platform to position our drug candidates in the right indications/populations and in smarter combination therapies.

52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy.

CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies.

Adni is revolutionizing how healthcare workers manage their careers by bringing everything they need into one AI-powered super app. From matching healthcare workers with high-paying jobs to purchasing gear and resources, updating credentials, networking with peers, and providing daily education, Adni's AI agents act as a trusted career copilot, helping healthcare workers save time and money—all within a single platform. For employers, Adni is the only all-in-one platform designed to both recruit and retain healthcare talent. Unlike traditional job boards, talent marketplaces, and recruiting software that focus solely on bringing in new healthcare workers, Adni helps employers recruit from our professional network and build happy, engaged teams through our white-labeled gamified intranet.

Anja Health is a personalized doctor-backed cord blood banking company that freezes umbilical cord and placenta stem cells. It sends a kit to soon-to-be parents in preparation for their birth experience. The baby's umbilical cord is clamped and cut immediately after birth, but Anja Health's offering allows for up to 2 minutes of delayed cord clamping. When users call the number on our collection kit to notify the shipping team that they've given birth, a medical courier picks up the collection kit from wherever they are in the United States and quickly delivers it to a lab within 72 hours or less. Similarly, the bank has a large number of Microfinance partners and institutions through which pertinent services are provided to all customers.

Apryl is a fertility benefits platform that helps in overcoming inequality.

52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy.

Noula is a precision hormonal health company, empowering patients with customized health insights and 1-on-1 coaching from experts. Our whole-person approach to care combines unique health data, including hormone biomarkers, genetics, nutrition, and lifestyle factors, and inclusive, virtual support from empathetic clinicians.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

Healthcare demand is rapidly outpacing capacity, the only way to solve this is early detection & prevention. We are building a Clinical Co-pilot that supports clinicians identify patient health changes earlier. We do this by combining healthcare data and translating it into powerful insights that support clinical decision-making (SaMD's :-). Long term vision is to build a human digital twin that understands everyone's health and informs clinicians (via the Clinical Co-pilot) about your health changes. Our secret sauce is a multimodal generative AI platform that translates any type of data streams into clinical insights and easily integrates into clinical workflows and IT systems.

Pear Bio is a Boston and London-based AI-enabled biotech company. We develop functional precision medicine-guided therapeutics for patients with hard-to-treat cancers. We take tumor biopsies and blood from cancer patients to find new targets with multi-omics. We then test the efficacy of generated drug candidates directly on patient tumor samples using a proprietary immune-microtumor system. We have best-in-class and first-in-class internal drug discovery programs, and we are using our 3D immune-microtumor platform to position our drug candidates in the right indications/populations and in smarter combination therapies.

Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx

contextflow revolutionizes the medical information search process with the help of deep learning: our 3D image-based search engine for radiologists looks for regions of interest within images (currently 18+ patterns in lung CTs); when a suspicious pattern is detected, we immediately find visually similar cases, descriptions and relevant reference information, affording doctors easy access to knowledge currently hidden in large medical image data and their associated reports...all within seconds. No more paging through books, guessing the right keyword or consulting various text-based reference search engines. In addition, our software can be configured to allow for prioritization of cases where patterns of interest are detected. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by a team of AI and engineering experts in July 2016, the company was awarded the distinction of Most Promising Startup by the BCS Search Industry, received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research and was selected as one of 19 startups out of over 700 applications to participate in the Philips HealthWorks accelerator program. It is currently testing its 3D image-based software with six partners, expanding internationally to other locations later this year.

Radiobotics are developing stellar machine learning algorithms, supporting doctors in analysing medical images, and making the right decisions.

Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow. The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant to facilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers. Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.

Radiobotics are developing stellar machine learning algorithms, supporting doctors in analysing medical images, and making the right decisions.

GLEAMER develops a suite of AI solutions for Radiology that encapsulate medical-grade expertise. The company wants to support imaging users to secure diagnoses for all patients at all times while improving efficiency. GLEAMER’s AI Companions are directly integrated into the users’ usual reading environment and act as an automated and transparent second reading to improve diagnostic accuracy in X-ray imaging. GLEAMER’s solutions are currently being used across 13 countries in more than 300 institutions.

Pear Bio is a Boston and London-based AI-enabled biotech company. We develop functional precision medicine-guided therapeutics for patients with hard-to-treat cancers. We take tumor biopsies and blood from cancer patients to find new targets with multi-omics. We then test the efficacy of generated drug candidates directly on patient tumor samples using a proprietary immune-microtumor system. We have best-in-class and first-in-class internal drug discovery programs, and we are using our 3D immune-microtumor platform to position our drug candidates in the right indications/populations and in smarter combination therapies.

Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading pharmaceutical companies and research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of novel treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers. We understand every body part. We speak human.

Ampersand is pioneering the development of behavioural science based digital medicines for people living with long term inflammatory conditions. We deliver measurable improvements in mental health and quality of life for patients and significant, well-evidenced savings for healthcare providers.

Whether you're a patient recovering from knee surgery or a desk worker starting to feel an ache in your back, the first step to getting you back to your best is getting an accurate measurement of your issue. Vitrue's products accurately and objectively measure musculoskeletal issues from the workplace to the clinic. VIDA is a tech-driven, fully managed service to reduce musculoskeletal problems like back and neck pain in desk workers. All while making companies DSE compliant for remote, office and hybrid teams. By assessing the quality of desk workers’ workspaces through cutting-edge AI, VIDA is a modern and scalable solution with impactful benefits. 65% of employees are living​​ with MSK issues like back or neck pain. In most cases, this is entirely preventable. With VIDA, you can empower your team to improve their workspace by giving them the knowledge they need to reduce pain and improve their quality of life. Vitrue EVVA uses depth sensors to perform clinical grade assessments of patients and is used in orthopaedics, elite sport injury prevention and preventative health screening. We provide computer vision based biomechanics measurement technology to assess your clients’ performance of gold standard functional movements pre and post treatment and throughout rehabilitation. We provide data to both clinicians and patients to ensure issues are detected early, optimal treatment can be designed and patients are informed and engaged throughout their experience. Our mission is to provide a new foundation for musculoskeletal healthcare and reduce MSK pain in millions of people.

Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.

contextflow revolutionizes the medical information search process with the help of deep learning: our 3D image-based search engine for radiologists looks for regions of interest within images (currently 18+ patterns in lung CTs); when a suspicious pattern is detected, we immediately find visually similar cases, descriptions and relevant reference information, affording doctors easy access to knowledge currently hidden in large medical image data and their associated reports...all within seconds. No more paging through books, guessing the right keyword or consulting various text-based reference search engines. In addition, our software can be configured to allow for prioritization of cases where patterns of interest are detected. contextflow is a spin-off of the Medical University of Vienna (MUW), Technical University of Vienna (TU) and European research project KHRESMOI. Founded by a team of AI and engineering experts in July 2016, the company was awarded the distinction of Most Promising Startup by the BCS Search Industry, received the Digital Innovation Award by the Austrian Federal Ministry of Education, Science and Research and was selected as one of 19 startups out of over 700 applications to participate in the Philips HealthWorks accelerator program. It is currently testing its 3D image-based software with six partners, expanding internationally to other locations later this year.

Arthronica’s technology is validating algorithms that can monitor and predict key disease activities in chronic rheumatic conditions.Arthronica is currently involved in clinical trials in the United Kingdom and United States.Arthronica joined Entrepreneur First, an international Talent Investor, which supports individuals to build technology companies, in the 11th London cohort.